NUVARING 15 micrograms/120 micrograms/24 hours, drug release system vaginal sachet, CIP 3400930102886
Active ingredients: Ethinylestradiol, Etonogestrel
Commercialized according to BDPMDispensing in France: Prescription only
Drug release systemsachet, CIP 3400930102886vaginale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NUVARING 15 microgrammes/120 microgrammes/24 heures, système de diffusion vaginal
- Pharmaceutical form
- système de diffusion
- Route of administration
- vaginale
- Presentation description
- 1 sachet(s) aluminium polyéthylène polytéréphtalate (PET) de 1 anneau(x) avec 1 applicateur(s)
- Marketing authorisation holder
- ORGANON FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Aug 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62148867CIP73010288CIP133400930102886Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTHINYLESTRADIOLsystème de diffusion | 2,7 mg · un système de diffusion vaginal | SA |
| ÉTONOGESTRELsystème de diffusion | 11,7 mg · un système de diffusion vaginal | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.